TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors

Scott T. Tagawa, Petros Grivas, Arash Rezazadeh Kalebasty et al.|Journal of Clinical Oncology|2021

Cited by 530